
STE
USDSTERIS plc (Ireland) Ordinary Shares
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$225.610
Kõrge
$225.905
Madal
$222.860
Maht
0.06M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
22.2B
Tööstusharu
Meditsiiniseadmed
Riik
United States
Kauplemisstatistika
Keskmine maht
0.56M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 26. apr 2025STERIS plc (STE): What's Happening with the Stock and What to Watch
Stock Symbol: STE Generate Date: 2025-04-26 23:00:54
Okay, let's break down what's been going on with STERIS plc stock lately. We'll look at the recent news, how the price has been moving, and what some predictions are saying.
Recent News Buzz
Three news items popped up recently. One is pretty standard stuff – STERIS announced they'll hold a conference call on May 15th to go over their financial results for the past fiscal year. Earnings calls are always a big deal because they give investors a look under the hood at how the company is actually performing.
Beyond that, we saw a couple of analyst opinions. JMP Securities reiterated their "Market Outperform" rating on the stock and kept their price target at $265. That's a positive signal; it means they think the stock should do better than the overall market and has room to climb from where it is now. On the flip side, Needham reiterated their "Hold" rating, which is more of a neutral stance – basically saying, "If you own it, keep it; if you don't, maybe wait and see."
So, the news is a bit mixed, leaning slightly positive thanks to that higher price target from JMP, but nothing earth-shattering. The main thing on the horizon is definitely that May 15th earnings call.
Price Check: What the Stock's Been Doing
Looking back at the last month or so, the price action for STE has been pretty interesting, and frankly, a bit choppy. In late March, the stock was trading mostly in the $220s. Then, in early April, it took a noticeable tumble, dipping below $210 for a moment. But it didn't stay down long, bouncing back sharply around April 9th. Since that bounce, it's been trading mostly in a range, roughly between $220 and $226. The last price we have is sitting right around $225. It hasn't been a smooth trend up or down; there's been some volatility in there.
What the AI Thinks
We also have a short-term prediction from an AI model. It's forecasting a bit of a dip in the immediate future. The prediction suggests a small decrease today, followed by larger percentage drops over the next couple of days. So, the AI is seeing some potential weakness right around the corner for the stock price.
Putting It All Together: Outlook & Ideas
So, where does all this leave us? We've got analysts with differing views (one bullish, one neutral), a stock price that's recovered from a recent dip but has been trading sideways, and an AI predicting a short-term slide. The company's own recommendation data highlights some strong technical signals and analyst optimism, which sounds good, but it also points out some fundamental weaknesses (like lower growth and higher debt) and notes that negative AI prediction.
It's a picture with conflicting signals. The technical indicators and one analyst suggest potential for the stock to move higher, possibly towards that $265 target eventually. But the AI prediction for the next few days is negative, the fundamentals aren't stellar, and the upcoming earnings call is a big unknown that could swing things either way.
Given this mixed bag, especially with earnings coming up, a cautious approach seems reasonable. However, if you're looking at potential moves based on the technical strength and the analyst's positive view, the data suggests that buying on a slight dip, perhaps if the price pulls back towards the $224-$225 area, could be something to consider.
If you decide to jump in, managing your risk is key. A potential stop-loss level noted in the data is around $217.95. This is below that recent dip area and could help limit losses if the stock price falls significantly. On the upside, a potential take-profit level is suggested around $229.39, which is near recent highs and could be a place to consider selling if the stock climbs.
Just remember, the AI is calling for a short-term drop, and those earnings results on May 15th are a major event that could override everything else we've discussed.
Company Snapshot
Just for context, STERIS is a major player in the Healthcare sector, specifically focused on Medical Devices and infection prevention. They provide equipment and services used in hospitals and by medical device manufacturers. So, the health of the healthcare industry and hospital spending trends are really important for this company.
Disclaimer: This analysis is based on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Seotud uudised
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year
JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
JMP Securities analyst David Turkaly reiterates Steris with a Market Outperform and maintains $265 price target.
Needham Reiterates Hold on Steristo Hold
Needham analyst Mike Matson reiterates Steris from Hold to Hold.
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 27. apr 2025, 19:02
63.6% Kindlus
Risk ja kauplemine
Sisenemispunkt
$223.72
Võta kasum
$229.39
Peata kahjum
$217.95
Põhitegurid
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.